Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/31/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Jinsy A. Andrews MD

Wrong Dr. Jinsy A. Andrews MD?

Director , Clinical Research and ...

Phone: (650) ***-****  
Email: j***@***.com
Cytokinetics , Incorporated
280 East Grand Avenue
South San Francisco , California 94080
United States

Company Description: Cytokinetics, Incorporated (Cytokinetics) is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Albany Medical College
  • Mailman School of Public Health
  • B.S.
    Union College
  • M.D.
    Albany Medical College
  • M.D.
    Columbia University
  • MSc
42 Total References
Web References
"This unique collaboration between ...
www.biospace.com [cached]
"This unique collaboration between Origent Data Sciences, Cytokinetics and The ALS Association reflects another step in our collective efforts to accelerate the clinical trial process and make new medicines available to people with ALS in desperate need of new therapeutic options," said Jinsy Andrews, M.D., Cytokinetics' Senior Director Clinical Research and Development and Head of Neuromuscular Therapeutics. "We are pleased to join with Origent to potentially validate their predictive model using datasets from BENEFIT-ALS and VITALITY-ALS which we hope may then facilitate the use of this novel technology to positively impact the design and conduct of future ALS clinical trials."Â
An oral presentation titled "The Effects ...
phx.corporate-ir.net [cached]
An oral presentation titled "The Effects of Tirasemtiv on Measures of Respiratory Function in Amyotrophic Lateral Sclerosis" was presented by Jinsy Andrews, MD, MSc, Director, Clinical Research and Development at Cytokinetics. Dr. Andrews summarized results on measures of respiratory function from BENEFIT-ALS and concluded that tirasemtiv may have had cumulative, longer term pharmacologic effects on Slow Vital Capacity (SVC) and that the effect of tirasemtiv on SVC appeared robust. In BENEFIT-ALS, the effect of tirasemtiv on SVC was similar in magnitude across all subgroups evaluated and was statistically significant within the majority of subgroups evaluated. Dr. Andrews observed that vital capacity is a clinically meaningful measure of disease progression and prognosis and is used to determine major clinical decisions in the treatment of patients with ALS.
An oral presentation titled "The Effects ...
ir.cytokinetics.com [cached]
An oral presentation titled "The Effects of Tirasemtiv on Measures of Respiratory Function in Amyotrophic Lateral Sclerosis" was presented by Jinsy Andrews, MD, MSc, Director, Clinical Research and Development at Cytokinetics. Dr. Andrews summarized results on measures of respiratory function from BENEFIT-ALS and concluded that tirasemtiv may have had cumulative, longer term pharmacologic effects on Slow Vital Capacity (SVC) and that the effect of tirasemtiv on SVC appeared robust. In BENEFIT-ALS, the effect of tirasemtiv on SVC was similar in magnitude across all subgroups evaluated and was statistically significant within the majority of subgroups evaluated. Dr. Andrews observed that vital capacity is a clinically meaningful measure of disease progression and prognosis and is used to determine major clinical decisions in the treatment of patients with ALS.
Cytokinetics will be ...
phx.corporate-ir.net [cached]
Cytokinetics will be represented by Robert I. Blum, President and Chief Executive Officer; Dr. Andrew A. Wolff, Senior Vice President of Clinical Research and Development and Chief Medical Officer; Dr. Fady I. Malik, Senior Vice President, Research and Early Development; and Dr. Jinsy Andrews, Â Director of Clinical Research and Medical Monitor of BENEFIT-ALS.
Cytokinetics will be ...
phx.corporate-ir.net [cached]
Cytokinetics will be represented by Robert I. Blum, President and Chief Executive Officer; Dr. Andrew A. Wolff, Senior Vice President of Clinical Research and Development and Chief Medical Officer; Dr. Fady I. Malik, Senior Vice President, Research and Early Development; and Dr. Jinsy Andrews, Â Director of Clinical Research and Medical Monitor of BENEFIT-ALS.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.